(R,R)-formoterol in combination with other pharmacological agents

Details for Australian Patent Application No. 2005231479 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Barberich, Timothy J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005231479

PCT Pub. Number WO2005/097095

Priority 60/559,015 05.04.04 US; 60/565,837 28.04.04 US

Filing date 5 April 2005

Wipo publication date 20 October 2005

Acceptance publication date 21 July 2011

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/404 (2006.01)

A61K 31/47 (2006.01) - Quinolines

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/097095 Priority application(s): WO2005/097095

17 March 2011 Alteration of Name

  The name of the applicant has been altered to Sunovion Pharmaceuticals Inc. 2006

21 July 2011 Application Accepted

  Published as AU-B-2005231479

24 November 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Oct 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

15 March 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Oct 2011

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005231485-Surgical hand access apparatus

2005231478-Modulation of NKG2D